| Autor: |
Varma A; Department of Medicine, Division of hematology, Oncology and Cell Therapy, The Coleman Foundation Blood and Marrow Transplant Center at Rush University Medical Center, Chicago, IL, USA. Ankur_Varma@rush.edu., Kosuri S; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA., Ustun C; Department of Medicine, Division of hematology, Oncology and Cell Therapy, The Coleman Foundation Blood and Marrow Transplant Center at Rush University Medical Center, Chicago, IL, USA., Ibrahim U; Bone Marrow Transplant and Cellular Therapy Program, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA., Moreira J; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Bishop MR; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA., Nathan S; Department of Medicine, Division of hematology, Oncology and Cell Therapy, The Coleman Foundation Blood and Marrow Transplant Center at Rush University Medical Center, Chicago, IL, USA., Mehta J; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Moncayo D; Bone Marrow Transplant and Cellular Therapy Program, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA., Heng J; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA., Osman K; Bone Marrow Transplant and Cellular Therapy Program, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA., Adekola KUA; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. |
Full text from SpringerLink